Tag: CinCor
AstraZeneca Buying CinCor For Up To $1.8 Billion
AstraZeneca has agreed to acquire to CinCor Pharma for $26.00 per share in cash plus a contingent value right of $10.00 per share in...
Privacy Overview
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.